Are mild hypertension guidelines driven by pharma ties?
In the early 2000s, I included “drugs for mild hypertension” in my book, Money-Driven Medicine: Tests and Treatments That Don’t Work. By 2007, I proposed a Cochrane systematic review of randomized controlled trials (RCTs) to settle the debate. Cochrane is widely considered the “gold standard” of evidence-based medicine; its reviews can shift global clinical practice and multibillion-dollar drug markets.
In 2012, Cochrane published the systematic review of Pharmacotherapy for …
Are mild hypertension guidelines driven by pharma ties?












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)





![Why hospital systems fail to notice the human behind the bill [PODCAST]](https://kevinmd.com/wp-content/uploads/ea65fd1d-d282-4c46-a750-620a3c3bb42f-190x100.jpeg)

